Executive Summary
On January 22, 2026, a surge of 46 regulatory filings under SEBI LODR Regulation 30 revealed intense post-listing activity among recent Indian IPOs and listed companies, dominated by analyst/investor meet intimations (over 15 instances) signaling robust institutional engagement likely tied to Q3 FY26 earnings anticipation. Neutral sentiment prevails across low-materiality routine disclosures, with sparse bullish signals from grants, awards, and orders offsetting minor risks like undisclosed legal matters. No fresh IPO filings emerged, but cumulative patterns highlight stable market momentum, alpha potential in high-engagement names, and sector maturation via governance tweaks.
Tracking the trend? Catch up on the prior India IPO SEBI DRHP Activity Filings digest from January 21, 2026.
Investment Signals(4)
- Vaibhav Global (532156)(BULLISH)▲
Step-down subsidiary secured US$2.76M non-dilutive ERC grant, enhancing liquidity
- Mahamaya Lifesciences (544611)(BULLISH)▲
Received 'Company of the Year' award at ICSCE 2026 Dubai post-IPO, boosting brand visibility
- Shree Pacetronix (527005)(BULLISH)▲
BSE trading approval for 75,150 promoter preferential shares at premium signals strong insider confidence
- Ceigall India (544223)(BULLISH)▲
Wholly-owned subsidiary awarded new order, indicating business pipeline momentum
Risk Flags(3)
- Cosmic CRF (543928)/Legal[MEDIUM RISK]▼
NCLAT order dated Jan 21 undisclosed post-IPO listing, potential corporate dispute or insolvency exposure
- Monarch Surveyors (544453)/Order Disclosure[MEDIUM RISK]▼
Incomplete details on new 'South East' order post-IPO, unclear revenue impact
- Ceigall India (544223)/Transparency▼
Order win lacks value, client, or timeline details, limiting materiality assessment
Opportunities(4)
Non-dilutive US$2.76M cash infusion supports expansion without equity dilution
International recognition enhances post-IPO investor appeal in lifesciences
Promoter capital infusion (~Rs 6M at premium) flags undervaluation and growth commitment
- Star Imaging (544482)/Empanelment◆
New tie-up with govt institute NIEPA opens recurring revenue streams
Sector Themes(3)
- Post-IPO Investor Engagement Boom◆
15+ analyst/investor meets (e.g., Home First, Windlas Biotech, Aeroflex) across recent listings signal institutional interest, potential for positive earnings surprises and re-ratings
- Governance Maturation Wave◆
Repeated director appointments (Zee Learn x3) and preferential issues indicate stabilizing boards, reducing key-man risks in nascent IPO cohort
- Business Wins Cluster◆
Orders (Ceigall, Monarch), grants (Vaibhav), awards (Mahamaya) in infra/lifesciences highlight execution momentum amid neutral macro
Watch List(4)
- Cosmic CRF (543928)👁
Monitor NCLAT order disclosures for litigation resolution impacting post-IPO stability
- Zee Learn (533287)👁
Track independent director integration and governance outcomes from multiple filings
- High-Engagement IPOs (Home First 543259, Windlas 543329)👁
Analyst meet outcomes for Q3 insights and trading catalysts
- Le Travenues (544192)👁
Q3/9M financial results details for growth validation post-ESOP grants
Filing Analyses(46)
22-01-2026
Cosmo First Ltd (BSE: 508814) provided an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, disclosed on BSE with event date January 22, 2026. The disclosure is categorized as an IPO Listing in the technology sector. No specific details, financials, or IPO parameters are mentioned in the filing.
22-01-2026
Ceigall India Ltd (544223) announced under Regulation 30 (LODR) the award/receipt of an order by its wholly-owned subsidiary, Ceigall Infra Projects Private Limited. The disclosure is dated January 22, 2026, sourced from BSE, and labeled as an IPO Listing event in the technology sector. No details on order value, terms, or financial impact are provided.
22-01-2026
Home First Finance Company India Ltd (BSE: 543259) announced an intimation under Regulation 30 (LODR) for the schedule of Analyst / Institutional Investor meetings, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The disclosure was made on January 22, 2026, via BSE, with the company positioned in the technology sector. No specific schedule details, financial metrics, or numerical data are provided.
22-01-2026
Tata Consumer Products Limited (BSE: 500800) issued an intimation under Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015, regarding an ESG rating update from NSE Sustainability Ratings and Analytics Limited. The disclosure was filed via BSE on January 22, 2026, and is labeled as an IPO Listing event but contains no IPO-related details. Sector noted as technology, though no business or financial specifics provided.
22-01-2026
Futuristic Solutions Ltd. (BSE: 534063), a technology sector company, filed a disclosure of Related Party Transactions for the half-year ended September 30, 2020, as per Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was sourced from BSE with event date January 22, 2026. No specific transaction details, values, or parties are mentioned in the provided filing summary.
22-01-2026
Vaibhav Global Ltd (BSE: 532156) has intimated under Regulation 30 of SEBI (LODR) Regulations, 2015, that its step-down subsidiary SHOPLC Global Inc., USA, received a grant of US$ 2.76 million (net of expenses) under the Employee Retention Credit (ERC) Scheme. The disclosure is dated January 22, 2026, sourced from BSE. No other financial or IPO-related details are provided in the filing.
22-01-2026
Shanthi Gears Ltd (BSE: 522034) made a disclosure pursuant to Regulations 30 and 31A of SEBI (LODR) Regulations 2015 on January 22, 2026, categorized as an IPO Listing event in the technology sector. No specific details on IPO stage, financials, shareholding changes, or material events are provided in the filing summary. This appears to be a routine regulatory compliance disclosure with no quantitative data disclosed.
22-01-2026
Thirani Projects Ltd (538464) announced non-applicability of Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended December 31, 2025. The disclosure was filed on January 22, 2026, via BSE. No financial metrics, transaction values, or shareholding details are mentioned.
22-01-2026
Windlas Biotech Ltd (BSE: 543329) announced under Regulation 30 (LODR) an intimation of the schedule for Analyst / Institutional Investor meetings per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement is sourced from BSE and dated January 22, 2026. No specific details on meeting schedules, participants, or outcomes are provided.
22-01-2026
KEI Industries Limited (BSE: 517569) announced under Regulation 30 (LODR) a Newspaper Publication as per Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with enclosures referenced. The event is labeled as IPO Listing on January 22, 2026, from BSE source in the technology sector. No specific details on IPO, financials, or transaction data are provided.
22-01-2026
Shree Pacetronix Ltd (BSE: 527005) has received trading approval from BSE Limited for 75,150 equity shares of Rs.10/- each, issued at a premium of Rs.71/- to the promoter on a preferential basis, bearing distinctive numbers from 3599401 to 3674550. This intimation is made pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. The company operates in the technology sector.
22-01-2026
IndoStar Capital Finance Limited announced allotment under Regulation 30 (LODR) on BSE, dated January 22, 2026, with stock code 541336. This intimation complies with para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015. Sector classified as technology; no specific allotment details, share counts, or financials disclosed.
22-01-2026
Star Imaging And Path Lab Limited (BSE: 544482) intimated under Regulation 30 of SEBI (LODR) Regulations, 2015, its empanelment with National Institute of Educational Planning And Administration (NIEPA). The disclosure was made on January 22, 2026, via BSE. No financial details, transaction values, or quantitative impacts are mentioned.
22-01-2026
KEI Industries Ltd (BSE: 517569) announced the outcome of an Analyst/Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure, dated January 22, 2026, from BSE, provides a link to the audio recording. No financial, operational, or IPO-related details are mentioned; sector noted as technology.
22-01-2026
Le Travenues Technology Ltd (BSE: 544192) announced on January 22, 2026, the outcome of its Nomination and Remuneration Committee meeting approving the grant of options under the company's Employees Stock Option Schemes. This is disclosed under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No quantitative details such as number of options, exercise price, or recipients are provided.
22-01-2026
Monte Carlo Fashions Ltd (538836) announced under Regulation 30 of SEBI (LODR) an Analyst/Investor Meet intimation. This is in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, with reference to the Board of Directors Meeting to be held on Wednesday. No financial or quantitative details provided in the disclosure.
22-01-2026
Grand Oak Canyons Distillery Ltd (523862) announced a change in its registered office address under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The disclosure complies with applicable provisions of LODR. No specific details on the new or old address, dates, or financial impacts are provided.
22-01-2026
Mahamaya Lifesciences Ltd (544611) announced receiving the prestigious 'Company of the Year - Medium Scale' award at ICSCE 2026 in Dubai, intimated under Regulation 30 of SEBI (LODR) Regulations, 2015. This follows its IPO listing on BSE on January 22, 2026, in the technology sector. No financial or quantitative details are disclosed in the filing.
22-01-2026
Colab Platforms Ltd (BSE: 542866) announced the outcome of its Board meeting held on January 22, 2026, where the Board approved the listing of equity shares on the Metropolitan Stock Exchange of India. The company is in the technology sector. No financial metrics, share counts, pricing, or other quantitative details were disclosed in the filing.
22-01-2026
Gravita India Ltd (BSE: 533282) announced an Analyst/Institutional Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation is dated January 22, 2026, sourced from BSE. No specific schedule details or numerical data are provided in the disclosure.
22-01-2026
Le Travenues Technology Ltd (BSE: 544192) announced financial results for the quarter and nine months ended December 31, 2025, under Regulation 30 and other applicable provisions of SEBI (LODR) Regulations, 2015. The disclosure is categorized as an IPO Listing event in the technology sector. No specific financial metrics, transaction values, or shareholding details are provided in the announcement.
22-01-2026
V-Mart Retail Ltd (BSE: 534976) has issued an intimation under Regulation 30 of the SEBI Listing Regulations regarding a change in Senior Management Personnel (SMP), specifically an appointment of SMP. The disclosure is dated January 22, 2026, from BSE source, labeled as 'IPO Listing' event type but pertains to post-listing management change. Sector noted as technology.
22-01-2026
Excel Industries Limited (BSE: 500650) announced closure of trading window pursuant to Regulation 29(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ahead of a Meeting of Board of Directors. The notice is dated January 22, 2026, sourced from BSE. No details on board meeting agenda, financials, or IPO-related information disclosed; sector noted as technology.
22-01-2026
Bayer CropScience Ltd (scrip 506285) issued an update disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, in furtherance to its previous disclosure on December 18, 2023. The announcement, sourced from BSE and dated January 22, 2026, is labeled as an IPO Listing event but provides no further details as the summary is truncated. Sector is noted as technology.
22-01-2026
BlueStone Jewellery and Lifestyle Limited (BSE: 544484) made an announcement under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding Management Commentary for Q3 FY26. The disclosure is linked to an IPO Listing event dated January 22, 2026, sourced from BSE. The company operates in the technology sector.
22-01-2026
Manorama Industries Ltd (BSE scrip: 541974) issued an intimation under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding an upcoming Analyst/Investor Meet related to Earnings. The announcement was sourced from BSE on January 22, 2026. No specific details on meet date, agenda, or financials were disclosed.
22-01-2026
Indo Borax & Chemicals Limited (BSE: 524342) announced an update on its Framework Agreement under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made via BSE on January 22, 2026, categorized as a Memorandum of Understanding/Agreements update. No financial details, transaction values, or specific agreement terms are mentioned.
22-01-2026
Firstsource Solutions Ltd (BSE: 532809) announced an Analyst/Institutional Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company enclosed a schedule for the meeting as part of this intimation dated January 22, 2026. This is a routine compliance disclosure in the technology sector for an already listed company.
22-01-2026
Paul Merchants Ltd. (BSE scrip: 539113) has provided an intimation under Regulation 30 of SEBI (LODR) Regulations, 2015, coinciding with its IPO listing event on January 22, 2026, sourced from BSE. The company operates in the technology sector. No specific details on IPO terms, financials, listing performance, or quantitative metrics are disclosed in the filing.
22-01-2026
SRF Ltd (BSE: 503806) made a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, announced on BSE on January 22, 2026. The event is described as an IPO Listing in the technology sector. No further details on the disclosure content, IPO specifics, financials, or other quantitative data are provided.
22-01-2026
Nilkamal Ltd (523385) disclosed an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, via BSE, categorized as an IPO Listing event on January 22, 2026, in the technology sector. No specific details on the intimation content, IPO terms, financials, or other metrics are provided in the filing.
22-01-2026
Shree Vatsaa Finance & Leasing Ltd. (BSE: 532007) intimated the cut-off date under Regulation 30 of SEBI (LODR) Regulations, 2015, and Rule 20 of Companies (Management and Administration) Rules, 2014, for determining member eligibility for dispatching Postal Ballot Notice. This is a routine compliance disclosure for a listed company, dated January 22, 2026, via BSE. No details on the specific cut-off date, postal ballot purpose, or financial/transaction data are provided.
22-01-2026
Cosmic CRF Ltd (BSE: 543928), a technology sector company, listed via IPO on BSE on January 22, 2026. The company intimated under Regulation 30 of SEBI (LODR) Regulations, 2015, regarding an NCLAT order dated January 21, 2026. No details on the NCLAT order content, financials, or IPO specifics are disclosed.
22-01-2026
Solarworld Energy Solutions Limited (scrip code 544532) announced an Analyst/Investor Meet under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation is dated January 22, 2026, sourced from BSE. No specific details on the meet schedule, venue, or participants were provided in the disclosure.
22-01-2026
Zee Learn Ltd (BSE: 533287) announced the appointment of an Additional Director in the category of Non-Executive Independent Director under Regulation 30 of SEBI (LODR). The intimation was disclosed via BSE on January 22, 2026. No specific name, financials, or other details provided in the announcement; sector noted as technology.
22-01-2026
Zee Learn Ltd (BSE: 533287) issued an intimation dated January 22, 2026, for the appointment of an Additional Director in the category of Non-Executive Independent Director pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015. This is a routine corporate governance disclosure from the already-listed company in the technology sector. No further details such as director's name, financials, or IPO-related information are provided.
22-01-2026
Sambhv Steel Tubes Limited (BSE: 544430) announced under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of a site visit as part of an Analyst/Investor Meet. This disclosure confirms post-listing compliance following IPO listing on January 22, 2026, sourced from BSE. No financial details, numerical values, or specific site visit schedule provided in the announcement.
22-01-2026
Dev Labtech Venture Ltd (BSE: 543848) intimated under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the strike-off of its wholly-owned subsidiary, Dev Labtech Venture Inc. (USA). The disclosure is dated January 22, 2026, sourced from BSE. No financial metrics, impacts, or further details are provided.
22-01-2026
Monarch Surveyors and Engineering Consultants Limited (BSE: 544453) announced under Regulation 30 of SEBI (LODR) Regulations 2015 the receipt of an order from South East (details incomplete). The announcement is dated January 22, 2026, sourced from BSE, following IPO listing in the technology and manufacturing sector. No order value, size, or financial impact disclosed.
22-01-2026
Aeroflex Industries Limited (BSE: 543972) announced under Regulation 30 (LODR) the intimation of schedule for Analyst/Institutional Investor meetings, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The disclosure is dated January 22, 2026, from BSE source. No specific meeting details, financials, or quantitative data provided.
22-01-2026
Jagsonpal Pharmaceuticals Ltd (BSE: 507789) announced the outcome of an Analyst/Investor Meet under Regulation 30 of SEBI (LODR) on January 22, 2026. This disclosure is in continuation of an earlier intimation dated January 15, 2026. No specific details on the meet proceedings, financials, or IPO-related information are provided.
22-01-2026
Zee Learn Ltd (BSE: 533287) has filed an intimation for the appointment of an Additional Director in the category of Non-Executive Independent Director pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made on January 22, 2026, via BSE. No specific details such as the director's name, background, or any financial metrics are provided in the filing.
22-01-2026
Saptak Chem And Business Ltd (BSE: 506906) announced unaudited financial results for the quarter ended December 31, 2025, along with the auditor's limited review report, pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made via BSE on January 22, 2026. Sector classified as technology; no specific financial metrics or details provided in the summary.
22-01-2026
Alivus Life Sciences Ltd (BSE:543322) announced the outcome of an Analyst/Investor Meet under Regulation 30 and 46 read with Part A of Schedule III of SEBI (LODR) Regulations 2015. The company confirmed that relevant documents have been uploaded. This is a standard compliance disclosure post-listing.
22-01-2026
Reliance Industries Limited (BSE: 500325) filed a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on January 22, 2026 via BSE. The event is categorized as IPO Listing in the technology sector, with an attached disclosure whose contents are not detailed here. No financial, numerical, or specific event details are provided in the summary.
22-01-2026
Fortis Healthcare Limited (scrip 532843) filed a disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 on BSE dated January 22, 2026, related to an IPO Listing event. The relevant disclosure is stated as attached but no further details provided. Sector described as technology, pharma.
Get daily alerts with 4 investment signals, 3 risk alerts, 4 opportunities and full AI analysis of all 46 filings
🇮🇳 More from India
View all →March 26, 2026
India Pre-Market Regulatory Roundup — March 26, 2026
India Pre-Market Regulatory Roundup
March 26, 2026
India Quarterly Results BSE NSE Announcements — March 26, 2026
India Quarterly Results BSE NSE Announcements
March 26, 2026
India Upcoming Corporate Actions BSE NSE — March 26, 2026
India Upcoming Corporate Actions BSE NSE
March 25, 2026
India Pre-Market Regulatory Roundup — March 25, 2026
India Pre-Market Regulatory Roundup